OpalMedica

Optellum

This company develops artificial intelligence software to assist clinicians in the early diagnosis and management of lung cancer and other pulmonary diseases.

Omica

This company develops artificial intelligence software to screen pathology slides for cancer biomarkers, serving hospital laboratories and biopharmaceutical partners to improve patient therapy selection.

FDNA

This company develops artificial intelligence phenotyping software to help clinicians and researchers identify rare diseases and genetic disorders in patients.

TMA Precision Health

This company provides a clinical decision support platform using genomic data and medical records to improve rare disease diagnosis for health systems and pharmaceutical partners.

Citizen Health

This company develops a data platform that aggregates medical records and provides AI-driven health insights for patients with rare and complex conditions.

Genorare

This company develops an encrypted artificial intelligence platform for hospitals and pharmaceutical firms to diagnose rare diseases using genomic and electronic health record data.

Imagen

This company develops artificial intelligence software for diagnostic testing and specialist consultations to support primary care providers.

AI Pathology

This company develops artificial intelligence software for cancer diagnosis and digital pathology image analysis to support pathologists and laboratories.